Should I buy or sell Health Catalyst stock right now?

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HCAT shares. View HCAT analyst ratings or view top-rated stocks .

What is Health Catalyst's stock price target for 2024?

11 Wall Street analysts have issued twelve-month price objectives for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they predict the company's share price to reach $12.10 in the next twelve months. This suggests a possible upside of 118.8% from the stock's current price. View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts .

How have HCAT shares performed in 2024?

Health Catalyst's stock was trading at $9.26 on January 1st, 2024. Since then, HCAT stock has decreased by 40.3% and is now trading at $5.53. View the best growth stocks for 2024 here .

Are investors shorting Health Catalyst?

Health Catalyst saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,520,000 shares, a drop of 16.5% from the March 15th total of 1,820,000 shares. Based on an average trading volume of 617,600 shares, the short-interest ratio is currently 2.5 days. View Health Catalyst's Short Interest .

When is Health Catalyst's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our HCAT earnings forecast .

How were Health Catalyst's earnings last quarter?

Health Catalyst, Inc. (NASDAQ:HCAT) announced its earnings results on Thursday, February, 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The company had revenue of $75.08 million for the quarter, compared to analyst estimates of $73.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 12.19% and a negative net margin of 39.92%.

What ETFs hold Health Catalyst's stock?

ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT) , ROBO Global Healthcare Technology and Innovation ETF (HTEC) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) . iShares U.S. Healthcare Providers ETF (IHF) .

What guidance has Health Catalyst issued on next quarter's earnings?

Health Catalyst updated its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million.

What is Dan Burton's approval rating as Health Catalyst's CEO?

501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com . Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.

What other stocks do shareholders of Health Catalyst own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA) , Salesforce (CRM) , Alteryx (AYX) , Walt Disney (DIS) , DocuSign (DOCU) , Block (SQ) , Slack Technologies (WORK) , ServiceNow (NOW) , Marvell Technology (MRVL) and PayPal (PYPL) .

When did Health Catalyst IPO?

Health Catalyst (HCAT) raised $129 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.

Who are Health Catalyst's major shareholders?

Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include Nepsis Inc. (1.98%) and Los Angeles Capital Management LLC (0.10%). Insiders that own company stock include Anita Pramoda , Benjamin Landry, Bryan Richard Hinton , Bryan Truman Hunt , Daniel D Burton , Daniel H Orenstein , Duncan Gallagher, James Patrick Jr Nelli , Jason Alger , Linda Llewelyn and Paul Horstmeier . View institutional ownership trends .

How do I buy shares of Health Catalyst?

Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:HCAT

Health Catalyst (HCAT) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free HCAT Stock Alerts

$5.58

-0.12 (-2.11%)

(As of 05:21 PM ET)

Compare

Today's Range: $5.51
▼
$5.68
50-Day Range: $5.53
▼
$10.26
52-Week Range: $5.51
▼
$14.37

Volume: 563,701 shs
Average Volume: 613,865 shs
Market Capitalization: $326.76 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $12.10

Get Health Catalyst alerts:

Health Catalyst MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.64 Rating Score
Upside/Downside: 118.8% Upside
$12.10 Price Target
Short Interest: Healthy
2.60% of Shares Sold Short
Dividend Strength: N/A
Sustainability: -0.91
Upright™ Environmental Score
News Sentiment: 0.59
Based on 7 Articles This Week
Insider Trading: Selling Shares
$12,251 Sold Last Quarter
Proj. Earnings Growth: Growing
From ($0.47) to ($0.28) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.85 out of 5 stars

Medical Sector

32nd out of 918 stocks

Computer Programming, Data Processing, & Other Computer Related Industry

3rd out of 57 stocks

4.3

Analyst's Opinion

Consensus Rating
Health Catalyst has received a consensus rating of Moderate Buy. The company's average rating score is 2.64, and is based on 7 buy ratings, 4 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Health Catalyst has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

5.0

Short Interest

Percentage of Shares Shorted
2.60% of the outstanding shares of Health Catalyst have been sold short.
Short Interest Ratio / Days to Cover
Health Catalyst has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Health Catalyst has recently decreased by 16.48%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Health Catalyst does not currently pay a dividend.
Dividend Growth
Health Catalyst does not have a long track record of dividend growth.

3.8

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
Health Catalyst has received a 48.83% net impact score from Upright. Health Catalyst seems to create the most significant positive value in categories "Taxes", "Creating knowledge", and "Physical diseases". The positive contribution in the "Creating knowledge" impact category is mostly driven by its "Health data collection software", "Data analytics services", and "Drug discovery software" products. See details.
Environmental Sustainability
The Environmental Impact score for Health Catalyst is -0.91.

2.6

News and Social Media Coverage

News Sentiment
Health Catalyst has a news sentiment score of 0.59. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
News Coverage This Week
MarketBeat has tracked 7 news articles for Health Catalyst this week, compared to 3 articles on an average week.
Search Interest
Only 3 people have searched for HCAT on MarketBeat in the last 30 days. This is a decrease of -57% compared to the previous 30 days.
MarketBeat Follows
8 people have added Health Catalyst to their MarketBeat watchlist in the last 30 days. This is an increase of 60% compared to the previous 30 days.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Health Catalyst insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,251.00 in company stock.
Percentage Held by Insiders
Only 2.70% of the stock of Health Catalyst is held by insiders.
Percentage Held by Institutions
85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Health Catalyst are expected to grow in the coming year, from ($0.47) to ($0.28) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Health Catalyst is -2.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Health Catalyst is -2.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Health Catalyst has a P/B Ratio of 0.87. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

About Health Catalyst Stock (NASDAQ:HCAT)

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

HCAT Stock Price History

30 days | 90 days | 365 days | Advanced Chart

HCAT Stock News Headlines

April 18, 2024 | insidertrades.com

Health Catalyst, Inc. (NASDAQ:HCAT) Insider Linda Llewelyn Sells 2,005 Shares

April 16, 2024 | americanbankingnews.com

Comparing WELL Health Technologies (OTCMKTS:WLYYF) & Health Catalyst (NASDAQ:HCAT)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

April 14, 2024 | americanbankingnews.com

Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Recommendation of "Moderate Buy" by Analysts

April 13, 2024 | seekingalpha.com

Oscar Health: Strong Industry Catalyst With Margin Expansion Potential

April 12, 2024 | americanbankingnews.com

Health Catalyst (NASDAQ:HCAT) Stock Rating Reaffirmed by KeyCorp

April 11, 2024 | americanbankingnews.com

Health Catalyst (NASDAQ:HCAT) Given "Overweight" Rating at Cantor Fitzgerald

March 17, 2024 | finance.yahoo.com

HCAT Dec 2024 10.000 put

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

March 17, 2024 | finance.yahoo.com

HCAT Apr 2024 7.500 put

March 16, 2024 | finance.yahoo.com

HCAT Apr 2024 10.000 call

March 16, 2024 | finance.yahoo.com

HCAT Dec 2024 17.500 call

March 11, 2024 | msn.com

Scientists design bifunctional catalyst to address environmental pollution problems

March 9, 2024 | seekingalpha.com

Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible

March 5, 2024 | finance.yahoo.com

Daniel Burton Bought 3.2% More Shares In Health Catalyst

March 4, 2024 | finance.yahoo.com

Health Catalyst to Participate in Upcoming Investor Conferences

February 28, 2024 | msn.com

Health Catalyst rises following disclosure of CEO share purchase

February 27, 2024 | prnewswire.com

Health Catalyst Names UnityPoint Health Winner of the 2024 Flywheel Award

February 27, 2024 | finance.yahoo.com

The 2024 Healthcare Analytics Summit (HAS) Kicks Off Today

February 26, 2024 | markets.businessinsider.com

Maintaining Buy Rating on Health Catalyst: Strong Sales Pipeline and Margin Outlook Offset Slower Growth Forecast

February 24, 2024 | ca.finance.yahoo.com

Bank of Canada to cut interest rates in half by end of next year: Desjardins

February 24, 2024 | finance.yahoo.com

Health Catalyst Full Year 2023 Earnings: EPS Misses Expectations

February 23, 2024 | markets.businessinsider.com

Optimistic Outlook: Health Catalyst’s Growth and Profitability Potential Affirm Buy Rating

February 23, 2024 | markets.businessinsider.com

Analyst Scoreboard: 5 Ratings For Health Catalyst

February 23, 2024 | finance.yahoo.com

Health Catalyst, Inc. (NASDAQ:HCAT) Q4 2023 Earnings Call Transcript

February 23, 2024 | finance.yahoo.com

Q4 2023 Health Catalyst Inc Earnings Call

February 22, 2024 | msn.com

Health Catalyst GAAP EPS of -$0.53 misses by $0.18, revenue of $75.08M beats by $1.49M

See More Headlines

Receive HCAT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/22/2024
Today: 4/19/2024
Next Earnings (Estimated): 5/14/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Computer programming, data processing, & other computer related
Sub-Industry: N/A
Current Symbol: NASDAQ:HCAT
CUSIP: N/A
CIK: 1636422
Web: www.healthcatalyst.com
Phone: (801) 708-6800
Fax: N/A
Employees: 1,300
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $12.10
High Stock Price Target: $16.00
Low Stock Price Target: $8.00
Potential Upside/Downside: +118.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.64
Research Coverage: 11 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($2.10)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-118,150,000.00
Net Margins: -39.92%
Pretax Margin: -39.80%
Return on Equity: -12.19%
Return on Assets: -6.51%

Debt

Debt-to-Equity Ratio: 0.62
Current Ratio: 4.42
Quick Ratio: 4.42

Sales & Book Value

Annual Sales: $295.94 million
Price / Sales: 1.09
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $6.38 per share
Price / Book: 0.87

Miscellaneous

Outstanding Shares: 58,560,000
Free Float: 56,982,000
Market Cap: $323.84 million
Optionable: Optionable
Beta: 1.29

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Mr. Daniel D. Burton (Age 48)
CEO & Director
Comp: $158.9k
Mr. Daniel H. Orenstein (Age 54)
Senior Advisor
Comp: $356.56k
Mr. Kevin Freeman (Age 51)
Chief Commercial Officer
Comp: $405.9k
Mr. Jason Alger (Age 40)
CFO & Chief Accounting Officer
Mr. Daniel LeSueur
Chief Operating Officer
Mr. Dave Ross
Chief Technology Officer
Mr. Adam Brown
Senior Vice President of Investor Relations and Financial Planning & Analysis
Mr. Benjamin Landry
General Counsel & Secretary of the Board
Ms. Tarah Neujahr Bryan
Chief Marketing & Communications Officer
Mr. Kyle J. Salyers
Chief Strategy Officer & Senior VP of Corporate Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

HCAT Stock Analysis - Frequently Asked Questions

Should I buy or sell Health Catalyst stock right now?: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Health Catalyst in the last year. There are currently 4 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" HCAT shares.
View HCAT analyst ratings or view top-rated stocks.
What is Health Catalyst's stock price target for 2024?: 11 Wall Street analysts have issued twelve-month price objectives for Health Catalyst's stock. Their HCAT share price targets range from $8.00 to $16.00. On average, they predict the company's share price to reach $12.10 in the next twelve months. This suggests a possible upside of 118.8% from the stock's current price.
View analysts price targets for HCAT or view top-rated stocks among Wall Street analysts.
How have HCAT shares performed in 2024?: Health Catalyst's stock was trading at $9.26 on January 1st, 2024. Since then, HCAT stock has decreased by 40.3% and is now trading at $5.53.
View the best growth stocks for 2024 here.
Are investors shorting Health Catalyst?: Health Catalyst saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 1,520,000 shares, a drop of 16.5% from the March 15th total of 1,820,000 shares. Based on an average trading volume of 617,600 shares, the short-interest ratio is currently 2.5 days.
View Health Catalyst's Short Interest.
When is Health Catalyst's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our HCAT earnings forecast.
How were Health Catalyst's earnings last quarter?: Health Catalyst, Inc. (NASDAQ:HCAT) announced its earnings results on Thursday, February, 22nd. The company reported ($0.21) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.06. The company had revenue of $75.08 million for the quarter, compared to analyst estimates of $73.67 million. Health Catalyst had a negative trailing twelve-month return on equity of 12.19% and a negative net margin of 39.92%.
What ETFs hold Health Catalyst's stock?: ETFs with the largest weight of Health Catalyst (NASDAQ:HCAT) stock in their portfolio include Fidelity Digital Health ETF (FDHT), ROBO Global Healthcare Technology and Innovation ETF (HTEC) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Healthcare Providers ETF (IHF).

What guidance has Health Catalyst issued on next quarter's earnings?: Health Catalyst updated its first quarter 2024 earnings guidance on Thursday, February, 22nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $72.5 million-$76.5 million, compared to the consensus revenue estimate of $79.0 million.
What is Dan Burton's approval rating as Health Catalyst's CEO?: 501 employees have rated Health Catalyst Chief Executive Officer Dan Burton on Glassdoor.com. Dan Burton has an approval rating of 99% among the company's employees. This puts Dan Burton in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 83.0% of employees surveyed would recommend working at Health Catalyst to a friend.
What other stocks do shareholders of Health Catalyst own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Health Catalyst investors own include NVIDIA (NVDA), Salesforce (CRM), Alteryx (AYX), Walt Disney (DIS), DocuSign (DOCU), Block (SQ), Slack Technologies (WORK), ServiceNow (NOW), Marvell Technology (MRVL) and PayPal (PYPL).
When did Health Catalyst IPO?: Health Catalyst (HCAT) raised $129 million in an initial public offering (IPO) on Thursday, July 25th 2019. The company issued 6,000,000 shares at a price of $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and William Blair served as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers.
Who are Health Catalyst's major shareholders?: Health Catalyst's stock is owned by a number of retail and institutional investors. Top institutional investors include Nepsis Inc. (1.98%) and Los Angeles Capital Management LLC (0.10%). Insiders that own company stock include Anita Pramoda, Benjamin Landry, Bryan Richard Hinton, Bryan Truman Hunt, Daniel D Burton, Daniel H Orenstein, Duncan Gallagher, James Patrick Jr Nelli, Jason Alger, Linda Llewelyn and Paul Horstmeier.
View institutional ownership trends.
How do I buy shares of Health Catalyst?: Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:HCAT) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial